Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Narrowing the field: cancer-specific promoters for mitochondrially-targeted p53-BH3 fusion gene therapy in ovarian cancer ; volume:12 ; number:1 ; day:30 ; month:4 ; year:2019 ; pages:1-12 ; date:12.2019
Journal of ovarian research ; 12, Heft 1 (30.4.2019), 1-12, 12.2019
- Creator
-
Bowman, Katherine Redd
Kim, Ji Hoon
Lim, Carol S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-019-0514-4
- URN
-
urn:nbn:de:101:1-2019061320521169874120
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bowman, Katherine Redd
- Kim, Ji Hoon
- Lim, Carol S.
- SpringerLink (Online service)
Other Objects (12)
BH3-mimetics: recent developments in cancer therapy
BH3 mimetics for the treatment of prostate cancer
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Identification of unique rectal cancer-specific subtypes
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality
Inherent variability of cancer-specific aneuploidy generates metastases
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations
ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer
Common germline polymorphisms associated with breast cancer-specific survival
Common germline polymorphisms associated with breast cancer-specific survival
Computational inference of cancer-specific vulnerabilities in clinical samples
BH3-mimetics: recent developments in cancer therapy
BH3 mimetics for the treatment of prostate cancer
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Identification of unique rectal cancer-specific subtypes
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality
Inherent variability of cancer-specific aneuploidy generates metastases
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations
ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer
Common germline polymorphisms associated with breast cancer-specific survival
Common germline polymorphisms associated with breast cancer-specific survival
Computational inference of cancer-specific vulnerabilities in clinical samples
BH3-mimetics: recent developments in cancer therapy
BH3 mimetics for the treatment of prostate cancer
Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer
Identification of unique rectal cancer-specific subtypes
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality
Inherent variability of cancer-specific aneuploidy generates metastases
Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations
ASO Author Reflections: Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer
Common germline polymorphisms associated with breast cancer-specific survival
Common germline polymorphisms associated with breast cancer-specific survival